IHC further demonstrated that miR-122-5p lentivirus treatment increased the expression of miR-122-5p and IGFBP4 in the tumor, suggesting that miR-122-5p can also promote the expression of IGFBP4 in vivo (Figs. 6d; S5G). The gene discussed is IGFBP4; the disease is neoplasm.